Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011, Article ID 484590, 10 pages
http://dx.doi.org/10.1093/ecam/nep052
Original Article

Preventive Effects of Salacia reticulata on Obesity and Metabolic Disorders in TSOD Mice

1Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
2Research Institute of Pharmaceutical Sciences, Musashino University, 1-1-20 Shinmachi Nishitokyo-shi, Tokyo 202-8585, Japan
3Graduate School of Natural Science and Technology, Kanazawa University, Kakuma-machi Kanazawa-shi, Ishikawa 920-1192, Japan
4Department of Pharmacy, Saiseikai Yokohama Tobu-Hospital, 3-6-1 Simosueyoshi Turumi-ku Yokohama-city, Kanagawa 230-0012, Japan
5Department of Pharmacy, Ritsumeikan University, 1-1-1 Noji-higashi, Kusatsu, Shiga 525-8577, Japan
6Graduate School of Medicine, Hokkaido University, North-15, West-7, Kita-ku, Hokkaido, 060-8638, Japan

Received 22 December 2008; Accepted 23 April 2009

Copyright © 2011 Tomoko Akase et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. L. Cooper, “Ayurveda is embraced by eCAM,” Evidence-Based Complementary and Alternative Medicine, vol. 5, no. 1, pp. 1–2, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Yoshikawa, T. Murakami, K. Yashiro, and H. Matsuda, “Kotalanol, a potent alpha-glucosidase inhibitor with thiosugar sulfonium sulfate structure, from antidiabetic ayurvedic medicine Salacia reticulata,” Chemical & Pharmaceutical Bulletin, vol. 46, pp. 1339–1340, 1998. View at Google Scholar
  3. N. C. Tewari, K. N. N. Ayengar, and S. Rangaswami, “Triterpenes of the root-bark of Salacia prenoides DC,” Journal of the Chemical Society, vol. 1, pp. 146–152, 1974. View at Google Scholar · View at Scopus
  4. A. T. Sneden, “Isoiguesterin, a new antileukemic bisnortriterpene from Salacia madagascariensis,” Journal of Natural Products, vol. 44, no. 4, pp. 503–507, 1981. View at Google Scholar · View at Scopus
  5. H. Matsuda, T. Murakami, K. Yashiro, J. Yamahara, and M. Yoshikawa, “Antidiabetic principles of natural medicines. IV. Aldose reductase and qlpha-glucosidase inhibitors from the roots of Salacia oblonga Wall. (Celastraceae): structure of a new friedelane-type triterpene, kotalagenin 16-acetate,” Chemical & Pharmaceutical Bulletin, vol. 47, pp. 1725–1729, 1999. View at Google Scholar
  6. J. N. Figueiredo, B. Räz, and U. Séquin, “Novel quinone methides from Salacia kraussii with in vitro antimalarial activity,” Journal of Natural Products, vol. 61, no. 6, pp. 718–723, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. E. H. Karunanayake and S. R. Sirimanne, “Mangiferin from the root bark of Salacia reticulata,” Journal of Ethnopharmacology, vol. 13, no. 2, pp. 227–228, 1985. View at Google Scholar · View at Scopus
  8. M. Yoshikawa, N. Nishida, H. Shimoda, M. Takada, Y. Kawahara, and H. Matsuda, “Polyphenol constituents from Salacia species: quantitative analysis of mangiferin with alpha-glucosidase and aldose reductase inhibitory activities,” Yakugaku Zasshi, vol. 121, pp. 371–378, 2001. View at Google Scholar
  9. A. Ghavami, B. D. Johnston, and B. M. Pinto, “A new class of glycosidase inhibitor: synthesis of salacinol and its stereoisomerst,” Journal of Organic Chemistry, vol. 66, no. 7, pp. 2312–2317, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Yoshikawa, T. Morikawa, H. Matsuda, G. Tanabe, and O. Muraoka, “Absolute stereostructure of potent α-glucosidase inhibitor, salacinol, with unique thiosugar sulfonium sulfate inner salt structure from Salacia reticulata,” Bioorganic and Medicinal Chemistry, vol. 10, no. 5, pp. 1547–1554, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Yoshikawa, H. Shimoda, N. Nishida, M. Takada, and H. Matsuda, “Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats,” Journal of Nutrition, vol. 132, no. 7, pp. 1819–1824, 2002. View at Google Scholar · View at Scopus
  12. T. H. Huang, G. Peng, G. Q. Li, J. Yamahara, B. D. Roufogalis, and Y. Li, “Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-α,” Toxicology and Applied Pharmacology, vol. 210, no. 3, pp. 225–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. T. H.-W. Huang, Q. Yang, M. Harada et al., “Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-α-mediated transcription of fatty acid metabolic genes,” Toxicology and Applied Pharmacology, vol. 210, no. 1-2, pp. 78–85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. T. H. Huang, L. He, Q. Qin et al., “Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor,” Diabetes, Obesity and Metabolism, vol. 10, no. 7, pp. 574–585, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. W. D. Ratnasooriya, J. R. Jayakody, and G. A. Premakumara, “Adverse pregnancy outcome in rats following exposure to a Salacia reticulata (Celastraceae) root extract,” Brazilian Journal of Medical and Biological Research, vol. 36, pp. 931–935, 2003. View at Google Scholar
  16. S. Iizuka, W. Suzuki, M. Tabuchi et al., “Diabetic complications in a new animal model (TSOD mouse) of spontaneous NIDDM with obesity,” Experimental Animals, vol. 54, no. 1, pp. 71–83, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. W Suzuki, “TSOD mice,” Diabetes Frontier, vol. 9, pp. 485–488, 1998. View at Google Scholar
  18. W. Suzuki, S. Iizuka, M. Tabuchi et al., “A new mouse model of spontaneous diabetes derived from ddY strain,” Experimental Animals, vol. 48, no. 3, pp. 181–189, 1999. View at Google Scholar · View at Scopus
  19. W. Suzuki and M. Tabuchi, “A new spontaneous type II diabetes model, TSOD mice (1): concerning the disease status,” Laboratory Animal Science and Technology, vol. 11, pp. 99–103, 1999. View at Google Scholar
  20. W. Suzuki, S. Iizuka, M. Tabuchi, T. Yanagisawa, and M. Kimura, “A new spontaneous type II diabetes model,” Diabetes Frontier, vol. 13, pp. 106–108, 2002. View at Google Scholar
  21. W. Suzuki and H. Nakajima, “Metabolic syndrome-related disease status of TSOD mouse,” Laboratory Animal Science and Technology, vol. 17, pp. 112–118, 2005. View at Google Scholar
  22. E. Kishino, T. Ito, K. Fujita, and Y. Kiuchi, “A mixture of the Salacia reticulata (Kotala himbutu) aqueous extract and cyclodextrin reduces the accumulation of visceral fat mass in mice and rats with high-fat diet-induced obesity,” Journal of Nutrition, vol. 136, pp. 433–439, 2006. View at Google Scholar
  23. S. Ozaki, H. Oe, and S. Kitamura, “α-glucosidase inhibitor from Kothala-himbutu (Salacia reticulata WIGHT),” Journal of Natural Products, vol. 71, no. 6, pp. 981–984, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Oe and S. Ozaki, “Hypoglycemic effect of 13-membered ring thiocyclitol, a novel α-glucosidase inhibitor from kothala-himbutu (Salacia reticulata),” Bioscience, Biotechnology and Biochemistry, vol. 72, no. 7, pp. 1962–1964, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Kataoka, “The hypoglycemic potential and safety profile of Salacia reticulate Wight extract powder in healthy and diabetic subjects,” New Diet Therapy, vol. 20, pp. 47–53, 2006. View at Google Scholar
  26. C. Tanimura, I. Terada, K. Hiramatu et al., “Effect of a mixture of aqueous extract from Salacia reticulate (Kotala himbutu) and cyclodextrin on the serum glucose and the insulin levels in sucrose tolerance test and on serum glucose level changes and gastro-intestinal disorder by massive ingestion,” Journal of the Yonago Medical Association, vol. 56, pp. 85–93, 2005. View at Google Scholar
  27. T. H.-W. Huang, Q. Yang, M. Harada et al., “Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-α-mediated transcription of fatty acid metabolic genes,” Toxicology and Applied Pharmacology, vol. 210, no. 1-2, pp. 78–85, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. T. H. Huang, G. Peng, G. Q. Li, J. Yamahara, B. D. Roufogalis, and Y. Li, “Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: activation of PPAR-α,” Toxicology and Applied Pharmacology, vol. 210, no. 3, pp. 225–235, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. C. P. Day and O. F. W. James, “Steatohepatitis: a tale of two “hits”?” Gastroenterology, vol. 114, pp. 842–845, 1998. View at Google Scholar
  30. Y. Li, T. H.-W. Huang, and J. Yamahara, “Salacia root, a unique Ayurvedic medicine, meets multiple targets in diabetes and obesity,” Life Sciences, vol. 82, no. 21-22, pp. 1045–1049, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Tsunakawa, T. Shimada, W. Suzuki et al., “Preventive effects of Daisaikoto on metabolic disorders in spontaneous obese type II diabetes mice,” Journal of Traditional Medicines, vol. 23, pp. 216–223, 2006. View at Google Scholar
  32. T. Shimada, T. Kudo, T. Akase, and M. Aburada, “Preventive effects of bofutsushosan on obesity and various metabolic disorders,” Biological and Pharmaceutical Bulletin, vol. 31, no. 7, pp. 1362–1367, 2008. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Shimada, T. Akase, M. Kosugi, and M. Aburada, “eCAM preventive effect of boiogito on metabolic disorders in the TSOD mouse, a model of spontaneous obese type II diabetes mellitus,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar